NEUROBIO:FT: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(13 intermediate revisions by the same user not shown) | |||
Line 66: | Line 66: | ||
=Seminário 5: Infecções= | =Seminário 5: Infecções= | ||
* Apresentação do tema [https://www.dropbox.com/s/evxyela1wzs3yqo/NB_FT_INFECTION.pptx Slides] | * Apresentação do tema [https://www.dropbox.com/s/evxyela1wzs3yqo/NB_FT_INFECTION.pptx Slides] | ||
#Kim SK. [https://www.dropbox.com/s/51ckg31ayokyviu/Pathogenesis%20of%20bacterial%20meningitis-%20from%20bacteraemia%20to%20neuronal%20injury.pdf Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury]. Nature Reviews Neuroscience (2003) 4:376-385. | |||
#van den Pol AN. [https://www.dropbox.com/s/8f3c2bqyq9sj68h/Viral%20infections%20in%20the%20developing%20and%20mature%20brain.pdf Viral infections in the developing and mature brain]. Trends in Neuroscience (2006) 29:398-406. | |||
=Seminário 6: Parkinson= | |||
* Apresentação do tema [https://www.dropbox.com/sh/xh2c08qgvmttt38/AgPPAwowd6 Slides] | |||
#Bandopadhyay R, de Belleroche J. [https://www.dropbox.com/sh/xh2c08qgvmttt38/AgPPAwowd6 Role of the ubiquitin proteasome system in Parkinson's disease]. Trends in Molecular Medicine (2010) 16:27-36. | |||
#Lim KL, Tan JMM. [https://www.dropbox.com/sh/xh2c08qgvmttt38/AgPPAwowd6 Role of the ubiquitin proteasome system in Parkinson's disease]. BMC Biochemistry (2007) 8(Suppl 1):S13 | |||
#Dunnett SB, Bjorklund A. [https://www.dropbox.com/sh/xh2c08qgvmttt38/AgPPAwowd6 Prospects for new restorative and neuroprotective treatments in Parkinson’s disease]. Nature (1999) 399 (Supp):A32-A39. | |||
<br> | |||
=Seminário 7: Distonias= | |||
* Apresentação do tema [https://www.dropbox.com/sh/ex4zg3ik3f3xakb/WWvlcMOHAY Slides] | |||
#Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG [https://www.dropbox.com/sh/ex4zg3ik3f3xakb/WWvlcMOHAY The pathophysiological basis of dystonias]. Nature Reviews Neuroscience (2008) 9: 222-234. | |||
# Tanabe LE, Kim CE, Alagem N, Dauer WT [https://www.dropbox.com/sh/ex4zg3ik3f3xakb/WWvlcMOHAY Primary dystonia: molecules and mechanisms]. Nature Reviews Neurology (2009) 5: 598–609. | |||
# Neychev VK, Gross RE, Lehéricy S, Hess EJ, Jinnah HA [https://www.dropbox.com/sh/ex4zg3ik3f3xakb/WWvlcMOHAY The functional neuroanatomy of dystonia]. Neurobiology of Disease (2011) 42:185-201. | |||
# Calderon DP, Fremont R, Kraenzlin F, Khodakhah K [https://www.dropbox.com/sh/ex4zg3ik3f3xakb/WWvlcMOHAY The neural substrates of rapid-onset Dystonia-Parkinsonism]. Nature Neuroscience (2011) 14:357-365. | |||
<br> | |||
=Seminário 8: Esclerose Múltipla= | |||
* Apresentação do tema [https://www.dropbox.com/s/al1jdkwspa6wx9i/NB_FT_EM.ppt Slides] | |||
#Hemmer B, Archelos JJ, Hartung HP. [https://www.dropbox.com/s/lezo0u4tn8cyf9a/Hemmer%202002.pdf New concepts in the immunopathogenesis of multiple sclerosis]. Nat Rev Neurosci (2002) 3(4):291-301. | |||
#Frohman EM, Racke MK, Raine CS. [https://www.dropbox.com/s/0hisiuvsp5jnc35/Froman%20review%20MS%20pathogenesis.pdf Multiple sclerosis-the plaque and its pathogenesis]. N Engl J Med (2006) 354(9):942-55. | |||
#Holmes S, Friese MA, Siebold C, Jones EY, Bell J, Fugger L.[https://www.dropbox.com/s/9308r3uo5y3auok/Multiple%20sclerosis%20MHC%20associations%20and%20therapeutic%20implications.pdf Multiple sclerosis: MHC associations and therapeutic implications]. Expert Rev Mol Med (2005) 7(3):1-17. | |||
#Venken K, Hellings N, Liblau R, Stinissen P. [https://www.dropbox.com/s/90humqh7muydw9p/Disturbed%20regulatory%20T%20cell%20homeostasis%20in%20multiple%20sclerosis.pdf Disturbed regulatory T cell homeostasis in multiple sclerosis]. Trends Mol Med (2010) 16(2):58-68. | |||
<!-- Replace everything above this line with information about your course. --> | <!-- Replace everything above this line with information about your course. --> | ||
</div> | </div> |